ReWalk Walking Device For Paraplegics Granted FDA Approval

June 29, 2014 | The ReWalk exoskeleton, a device that helps paraplegics walk, announced that its life-changing device was certified by the FDA in the United States. The device, which straps on to the user’s legs and involves the use of crutches to allow those usually confined to wheelchairs to traverse various indoor and outdoor environments, costs about €52,500 ($72,000) in Europe. The US pricing for the device has yet to be revealed. The ReWalk device was created in 2011 by Israeli company Argo Medical Technologies’ founder Dr. Amit Goffer, who himself is a quadriplegic.